INCYTE CORP — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2023-01-04

Reporting Person: Stein Steven H (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-04	Common Stock	S	28399	$79.78	Disposed	109021	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.

F2: This includes an aggregate of 87,510 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.